Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
|Videos|June 9, 2017
Ilana Cass on Potential Consequences of Preventive Surgery
Author(s)Ilana Cass, M.D.
Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.
Advertisement
Ilana Cass, M.D. of Cedars-Sinai Medical Center, discusses the potential side effects that may occur after a preventive surgery for ovarian cancer. Some of the effects are yet unknown and standards for screening need to be developed.
Advertisement
Related to this article
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Dr. Sara Hurvitz explains why giving Enhertu before surgery didn't change care for HER2-low, HR-positive early breast cancer, and what patients should know.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient cancer.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Nearly Half of Cancer Survivors Report Recent Alcohol Use
3
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5